The measurement of urinary total protein continues to have a place in the repertoire of clinical laboratory tests, particularly in the clinical assessment of patients with renal disease. Although the test volume is often modest, there exists the need to perform the assay on the major automated chemistry analyzers currently in use in most hospital laboratories. We have evaluated the performance of a new urine total protein procedure developed for dry reagent slide technology for use on the Vitros 950 analyzer (Johnson & Johnson). In this method, protein in the sample binds to a pyrocatechol violet-molybdate complex, resulting in an absorption shift. The method is calibrated with aqueous solutions of bovine serum albumin supplied by Johnson & Johnson. We compared the new method with that in current use on the Cobas Fara analyzer (Hoffmann-La Roche), which involves pyrogallol red dye binding of urine total protein [1] calibrated with human serum albumin (Biotrol). For this comparison we analyzed 53 patient samples (median 0.65 g/L, range 0.02-5.44 g/L, pyrogallol red results) and obtained the following Deming linear regression analysis: r ϭ 0.807, slope ϭ 3.01, intercept ϭ Ϫ1.19 g/L, S y͉x ϭ 0.72 g/L (x ϭ Cobas Fara pyrogallol red, y ϭ Vitros method). These results showed a strong positive bias with the Vitros method with respect to the pyrogallol red method. The differences between the procedures appeared greatest in samples that required dilution, i.e., those Ͼ2.00 g/L, the linear range of both methods. Dilutions, when required, were carried out with deionized water in accordance with both manufacturers' instructions. Deming linear regression analysis of the samples that did not require dilution (n ϭ 36, median 0.23 g/L, range 0.02-1.51 g/L, pyrogallol red results) gave the following: r ϭ 0.980, slope ϭ 1.16, intercept ϭ 0.06 g/L, S y͉x ϭ 0.06 g/L. Thus the discrepancies between the two methods were markedly increased when dilutions were involved.
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At this point, three specimens were analyzed with Vitros methodology with various dilutions in deionized water; the results are given in Table 1 . Clearly, urine total protein measurements with Vitros methodology are dilution dependent, showing an increasing positive bias the greater the dilution. Similar results were obtained with human serum albumin/deionized water solutions (data not shown). We hypothesize that the denaturing conditions of a deionized water dilution enhances the reaction of the proteins.
Because urine contains a relatively high concentration of potassium, the three specimens were then diluted with 150 and 75 mmol/L KCl solutions and analyzed as before. These results are also shown in Table 1 . The KCl concentrations were chosen to reflect the normal range of potassium excretion in urine (25-125 mmol per day [2] ). They show that the use of a KCl solution effectively reduces the large positive bias observed when deionized water alone is used as the diluent. The same response to KCl was observed when human serum albumin solutions were analyzed (data not shown).
To validate further the modified dilution protocol we compared the pyrogallol red and Vitros methods to a manual biuret reference procedure. This method provides essentially equal sensitivity for different proteins and is claimed to be the most accurate procedure for urine total Table 2 . It is clear from the Deming linear regression analyses in Table 2 that the Vitros method, with dilution with 75 mmol/L KCl for samples Ͼ2.00 g/L, agrees well with the biuret reference method, which strongly suggests that this provides an accurate measurement of urine total protein concentration. These results, combined with the multiple dilutions shown in Alcohol dehydrogenase (ADH; EC 1.1.1.1.) is a zinc metalloenzyme with at least five classes. Class I enzymes (␣, ␤, and ␥) form homodimeric and heterodimeric isoenzymes, the subunits of which are encoded by the ADH1, ADH2, and ADH3 genes, respectively, and play an important role in the metabolism of ingested ethanol. Among the ␣, ␤, and ␥ enzymes, the largest kinetic differences occur in the three polymorphic variants at ADH2. A G-to-A transition that resulted in conversion of arginine 47 (␤1, encoded by ADH2 1 ) to histidine (␤2, encoded by ADH2
2 ) in exon 3, and a substitution of an arginine 369 to cystine (␤3, encoded by ADH2
3 ) of the ADH2 gene have been observed. We have focused on ADH2 1 and ADH2 2 , as ␤3 has been identified only in Africans [1] . The atypical enzymes involving the ␤2 subunit(s) have a high activity as indicated by V max values [2, 3] , but the significance of ADH2 genotypes in patients with alcohol-related problems is still controversial: Takeshita et al. reported that drinking habits were not significantly associated with the ADH2 genotype [4] ; Muramatsu et al. reported that the ADH2 2 /2 2 homozygote appeared less frequently in nonalcoholic subjects (though not statistically significantly) and that the ADH2 2 allele was present with significantly lower incidence among alcoholics than nonalcoholics [5] ; and Tanaka et al. reported that the ADH2 genotype played important roles in habitual alcohol-intake behavior [6] . The ADH1, ADH2, and ADH3 genes are closely related, and share 94% homology in their coding nucleotide sequences [7] . Researchers have reported methods for the detection of the ADH2
1 and ADH2 2 genotypes with genomic DNA with allele-specific oligonucleotides (ASO) [8] , the dotblot hybridization of PCR product with ASO [9] , PCR coupled with restriction fragment length polymorphism (RFLP) [9, 10] , and direct sequencing of the PCR product [6] . The present communication reports a new rapid inexpensive and reliable method for genotype determination of ADH2 1 and ADH2 2 involving nail clippings. After informed consent was obtained from 120 healthy Japanese, nails were collected with an ordinary nail clipper cleaned with 700 mL/L ethanolic cotton pad. Blood samples were collected from 20 of these. Between 20 and 30 mg of nail clippings, or the sediment from a 100-L blood sample, in a 1.5-mL microtest tube was mixed with 300 L of 4 mol/L guanidine thiocyanate, 5 g/L sodium N-lauroyl salcosinate, 25 mmol/L sodium citrate, and 0.1 mol/L 2-mercaptoethanol [11], and was then incubated for 30 min at room temperature. Nucleic acids were extracted with phenol/chloroform {TE buffer [10mmol/L Tris-HCl (pH 8.0), 1 mmol/L EDTA (pH 8.0)] saturated}, and then precipitated with ethanol and sodium chloride. After centrifugation, the pellet was dissolved in 30 L of TE buffer diluted 1:10. One-fifth of the genomic DNA from nail, or one-tenth of that from a blood sample was subjected to 30 cycles of amplification with the following primers respectively; primer MF3: 5Ј-CTG-TAGGAATCTGTC-3Ј; MR3: 5Ј-CCTTCTCCAACACTA-3Ј (Fig. 1A) . These primers were designed as mismatched 3Ј-end nucleotides of the ADH1 or ADH3 alleles for amplifying only the ADH2 allele. The PCR reaction was conducted in a final volume of 25 L containing 6 L of genomic DNA, 200 mol/L dNTP mix, 1ϫ PCR buffer (Nippon Gene), 0.4 mol/L of each primer, and 0.625 U of Taq DNA polymerase, an N-terminal truncated 68-kDa polymerase (Nippon Gene). PCR variables were: 94°C for the first 4 min for denaturation, followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 52°C for 30 s, and extension at 72°C for 30 s. The amplified DNA fragments were digested with MslI and underwent electrophoresis in an 8% polyacrylamide gel, and were then visualized by ethidium bromide staining. The ADH2
